Skip to main content
SpringerLink
Log in

Dietary Supplements in Older Adults

  • Chapter
  • First Online:
Handbook of Clinical Nutrition and Aging

Part of the book series: Nutrition and Health ((NH))

  • 3446 Accesses

Abstract

The chapter reviews dietary supplements in older adults. A brief introduction covering the dietary supplement marketplace, types of dietary supplements, motivations for their use by older Americans, and market trends is followed by a brief discussion of the regulation of these products. The safety and effectiveness of nutrient supplements including multi-vitamin mineral products, calcium and vitamin D containing supplements, combinations of vitamins, minerals and other nutrients for specific conditions, vitamins (B complex, and E), minerals (potassium, selenium, and omega 3 and 6 fatty acids) commonly used by the elderly are discussed. The effectiveness and safety of certain non-nutrient supplements used by older Americans is also reviewed for herbals and botanicals (soy, black cohosh, saw palmetto, gingko biloba) and non-nutrient non-botanicals (glucosamine/chondroitin, coQ10). Guidelines for the safe use of supplements by the elderly are summarized, and continuing concerns enumerated.

Note: The findings and views reported in this chapter represent those of the contributing authors and not necessarily those of the National Institutes of Health and are not intended to constitute an “authoritative statement” under the Food and Drug Administration rules and regulations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Buhr G, Bales CW. Nutritional supplements for older adults: review and recommendations-part I. J Nutr Elder. 2009;28(1):5–29.

    PubMed  Google Scholar 

  2. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE, Falconer G, Green CL. Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D. Am J Clin Nutr. 1995;61:1140–5.

    CAS  PubMed  Google Scholar 

  3. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med. 1992;327(23):1637–42.

    CAS  PubMed  Google Scholar 

  4. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354(7):669–83.

    CAS  PubMed  Google Scholar 

  5. Grant AM, Avenell A, Campbell MK, McDonald AM, MacLennan GS, McPherson GC, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet. 2005;365(9471):1621–8.

    CAS  PubMed  Google Scholar 

  6. O’Brien KO. Combined calcium and vitamin D supplementation reduces bone loss and fracture incidence in older men and women. Nutr Rev. 1998;56:148–58.

    PubMed  Google Scholar 

  7. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academies Press; 2011.

    Google Scholar 

  8. Picciano MF, Yetley EA, Coates PM. Folate and health. CAB Rev Perspect Agric Vet Sci Nutr Nat Resour [Internet]. 2007 June 20, 2013; 2:[No. 018 p.]. Available from: http://www.cabi.org/cabreviews/?loadmodule=review&page=4051&reviewid=29483&site=167.

  9. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med. 1998;49:31–62.

    CAS  PubMed  Google Scholar 

  10. Tawakol A, Migrino RQ, Aziz KS, Waitkowska J, Holmvang G, Alpert NM, et al. High-dose folic acid acutely improves coronary vasodilator function in patients with coronary artery disease. J Am Coll Cardiol. 2005;45:158–64.

    Google Scholar 

  11. Holick MF. Vitamin D, deficiency. N Engl J Med. 2007;357(3):266–81.

    CAS  PubMed  Google Scholar 

  12. Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155(12):827–38.

    PubMed  Google Scholar 

  13. Bailey RL, Gahche JJ, Miller PE, Thomas PR, Dwyer JT. Why US adults use dietary supplements. JAMA Intern Med. 2013;173(5):355–61.

    CAS  PubMed  Google Scholar 

  14. Schmidt BM, Ribnicky DM, Lipsky PE, Raskin I. Revisiting the ancient concept of botanical therapeutics. Nat Chem Biol. 2007;3(7):360–6.

    CAS  PubMed  Google Scholar 

  15. Fugh-Berman A. Herb-drug interactions. Lancet. 2000;355:134–8.

    CAS  PubMed  Google Scholar 

  16. Journal NB. Supplement business report 2012. San Diego, CA: New Hope Natural Media, Penton Media Inc.; 2012.

    Google Scholar 

  17. Rovati LC, Girolami F, Persiani S. Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic properties. Ther Adv Musculoskelet Dis. 2012;4(3):167–80.

    CAS  PubMed Central  PubMed  Google Scholar 

  18. Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR, et al. Dietary supplement use in the United States, 2003–2006. J Nutr. 2011;141(2):261–6.

    CAS  PubMed Central  PubMed  Google Scholar 

  19. Kishiyama SS, Leahy MJ, Zitzelberger TA, Guariglia R, Zajdel DP, Calvert Jr JF, et al. Patterns of dietary supplement usage in demographically diverse older people. Altern Ther Health Med. 2005;11(3):48–53.

    PubMed Central  PubMed  Google Scholar 

  20. Bardia A, Nisly NL, Zimmerman BM, Gryzlak BM, Wallace RB. Use of herbs among adults based on evidence-based indications: findings from the National Health Interview Survey. Mayo Clin Proc. 2007;82(5):561–6.

    PubMed Central  PubMed  Google Scholar 

  21. Nahin RL, Byrd-Clark D, Stussman BJ, Kalyanaraman N. Disease severity is associated with the use of complementary medicine to treat or manage type-2 diabetes: data from the 2002 and 2007 National Health Interview Survey. BMC Complement Altern Med. 2012;12:193.

    PubMed Central  PubMed  Google Scholar 

  22. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Rompay MV, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA. 1998;280:1569–75.

    CAS  PubMed  Google Scholar 

  23. Sloan E. Why people use vitamin and mineral supplements. Nutr Today. 2007;42(2):55–61.

    Google Scholar 

  24. Health Focus International. The 2005 HealthFocus trend report: a national study of public attitudes and actions toward shopping and eating. St. Petersburg, FL: HealthFocus International; 2005.

    Google Scholar 

  25. U.S. Food and Drug Administration. Draft guidance for industry: dietary supplements: new dietary ingredient notifications and related issues 2011 [August 7, 2013]. Available from: http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/DietarySupplements/ucm257563.htm.

  26. Jialal I, Devaraj S. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med. 2000;342(25):1917–8.

    CAS  PubMed  Google Scholar 

  27. Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005;293(11):1338–47.

    PubMed  Google Scholar 

  28. Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women’s Health Study: a randomized controlled trial. JAMA. 2005;294(1):56–65.

    CAS  PubMed  Google Scholar 

  29. Klein EA, Thompson Jr IM, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306(14):1549–56.

    CAS  PubMed Central  PubMed  Google Scholar 

  30. Ebbing M, Bonaa KH, Nygard O, Arnesen E, Ueland PM, Nordrehaug JE, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA. 2009;302(19):2119–26.

    CAS  PubMed  Google Scholar 

  31. Andreeva VA, Touvier M, Kesse-Guyot E, Julia C, Galan P, Hercberg S. B vitamin and/or omega-3 fatty acid supplementation and cancer: ancillary findings from the supplementation with folate, vitamins B6 and B12, and/or omega-3 fatty acids (SU.FOL.OM3) randomized trial. Arch Intern Med. 2012;172(7):540–7.

    CAS  PubMed  Google Scholar 

  32. Song Y, Manson JE, Lee IM, Cook NR, Paul L, Selhub J, et al. Effect of combined folic acid, vitamin B(6), and vitamin B(12) on colorectal adenoma. J Natl Cancer Inst. 2012;104(20):1562–75.

    CAS  PubMed Central  PubMed  Google Scholar 

  33. Gibson TM, Weinstein SJ, Pfeiffer RM, Hollenbeck AR, Subar AF, Schatzkin A, et al. Pre- and postfortification intake of folate and risk of colorectal cancer in a large prospective cohort study in the United States. Am J Clin Nutr. 2011;94(4):1053–62.

    CAS  PubMed Central  PubMed  Google Scholar 

  34. National Eye Institute. Eye health needs of older adults literature review [August 7, 2013]. Available from: http://www.nei.nih.gov/nehep/research/The_Eye_Health_needs_of_Older_Adults_Literature_Review.pdf.

  35. U.S. Food and Drug Administration. Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements; Final Rule. Fed Regis 72(121):34751–958 Washington, DC: Food and Drug Administration; 2007 [cited 2013 June 20]. Available from: http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/DietarySupplements/ucm238182.htm.

  36. Corby-Edwards AK. Regulation of dietary supplements. Washington, DC: Congressional Research Service; 2013. p. 21.

    Google Scholar 

  37. Coates PM, Dwyer JT, Thurn AL. Introduction to state-of-the-science conference: multivitamin/mineral supplements and chronic disease prevention. Am J Clin Nutr. 2007;85(1):255S–6.

    CAS  Google Scholar 

  38. U.S. Preventive Services Task Force. Routine vitamin supplementation to prevent cancer and cardiovascular disease: recommendations and rationale. Ann Intern Med. 2003;139(1):51–5.

    Google Scholar 

  39. World Cancer Research Fund, American Institute for Cancer Prevention. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research; 2007.

    Google Scholar 

  40. Mursu J, Robien K, Harnack LJ, Park K, Jacobs Jr DR. Dietary supplements and mortality rate in older women: the Iowa Women’s Health Study. Arch Intern Med. 2011;171(18):1625–33.

    CAS  PubMed Central  PubMed  Google Scholar 

  41. Macpherson H, Pipingas A, Pase MP. Multivitamin-multimineral supplementation and mortality: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2013;97(2):437–44.

    CAS  PubMed  Google Scholar 

  42. Chan AL, Leung HW, Wang SF. Multivitamin supplement use and risk of breast cancer: a meta-analysis. Ann Pharmacother. 2011;45(4):476–84.

    CAS  PubMed  Google Scholar 

  43. Stratton J, Godwin M. The effect of supplemental vitamins and minerals on the development of prostate cancer: a systematic review and meta-analysis. Fam Pract. 2011;28(3):243–52.

    PubMed  Google Scholar 

  44. Park Y, Spiegelman D, Hunter DJ, Albanes D, Bergkvist L, Buring JE, et al. Intakes of vitamins A, C, and E and use of multiple vitamin supplements and risk of colon cancer: a pooled analysis of prospective cohort studies. Cancer Causes Control. 2010;21(11):1745–57.

    PubMed Central  PubMed  Google Scholar 

  45. Prentice RL. Clinical trials and observational studies to assess the chronic disease benefits and risks of multivitamin-multimineral supplements. Am J Clin Nutr. 2007;85(1):308S–13.

    CAS  PubMed  Google Scholar 

  46. Stephen AI, Avenell A. A systematic review of multivitamin and multimineral supplementation for infection. J Hum Nutr Diet. 2006;19(3):179–90.

    PubMed  Google Scholar 

  47. Grima NA, Pase MP, Macpherson H, Pipingas A. The effects of multivitamins on cognitive performance: a systematic review and meta-analysis. J Alzheimers Dis. 2012;29(3):561–9.

    CAS  PubMed  Google Scholar 

  48. McNeill G, Avenell A, Campbell MK, Cook JA, Hannaford PC, Kilonzo MM, et al. Effect of multivitamin and multimineral supplementation on cognitive function in men and women aged 65 years and over: a randomised controlled trial. Nutr J. 2007;6:10.

    PubMed Central  PubMed  Google Scholar 

  49. Institute of Medicine. Dietary reference intakes: water, potassium, sodium, chloride, and sulfate. Washington, DC: National Academies Press; 2004.

    Google Scholar 

  50. Bailey RL, Dodd KW, Goldman JA, Gahche JJ, Dwyer JT, Moshfegh AJ, et al. Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr. 2010;140(4):817–22.

    CAS  PubMed Central  PubMed  Google Scholar 

  51. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes: applications in dietary assessment. Washington, DC: National Academies Press; 2000.

    Google Scholar 

  52. U.S. Food and Drug Administration. Guidance for industry: a food labeling guide—health claims: calcium and osteoporosis. 21 CFR 101.72. Washington, DC: Food and Drug Administration; 1993 [cited 2013 June 20]. Available from: http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/LabelingNutrition/ucm064919.htm.

  53. Gass M, Dawson-Hughes B. Preventing osteoporosis-related fractures: an overview. Am J Med. 2006;119(4):S3–11.

    PubMed  Google Scholar 

  54. Office of the Surgeon General. Bone health and osteoporosis: a report of the Surgeon General. Rockville, MD: Office of the Surgeon General, Department of Health and Human Services; 2004.

    Google Scholar 

  55. Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES, et al. Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(6):1802–22.

    CAS  PubMed  Google Scholar 

  56. Nordin BE. The effect of calcium supplementation on bone loss in 32 controlled trials in postmenopausal women. Osteoporos Int. 2009;20(12):2135–43.

    CAS  PubMed  Google Scholar 

  57. Rabenda V, Bruyere O, Reginster JY. Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression. Osteoporos Int. 2011;22(3):893–901.

    CAS  PubMed  Google Scholar 

  58. Langsetmo L, Berger C, Kreiger N, Kovacs CS, Hanley DA, Jamal SA, et al. Calcium and vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos). J Clin Endocrinol Metab. 2013;98:3010–8.

    CAS  PubMed  Google Scholar 

  59. Posadzki P, Lee MS, Onakpoya I, Lee HW, Ko BS, Ernst E. Dietary supplements and prostate cancer: a systematic review of double-blind, placebo-controlled randomised clinical trials. Maturitas. 2013;75(2):125–30.

    CAS  PubMed  Google Scholar 

  60. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417–36.

    PubMed Central  Google Scholar 

  61. Tan JSL, Wang JJ, Flood V, Rochtchina E, Smith W, Mitchell P. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Am Acad Ophthalmol. 2008;115(2):334–41.

    Google Scholar 

  62. Age-Related Eye Disease Study Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19):2005–15.

    Google Scholar 

  63. Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database Syst Rev. 2012;6, CD000253.

    PubMed  Google Scholar 

  64. Ma L, Dou HL, Wu YQ, Huang YM, Huang YB, Xu XR, et al. Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis. Br J Nutr. 2012;107(3):350–9.

    CAS  PubMed  Google Scholar 

  65. Andres E, Fothergill H, Mecili M. Efficacy of oral cobalamin (vitamin B12) therapy. Expert Opin Pharmacother. 2010;11(2):249–56.

    CAS  PubMed  Google Scholar 

  66. Andres E, Vogel T, Federici L, Zimmer J, Kaltenbach G. Update on oral cyanocobalamin (vitamin B12) treatment in elderly patients. Drugs Aging. 2008;25(11):927–32.

    CAS  PubMed  Google Scholar 

  67. Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, Manson JE, et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37,485 individuals. Arch Intern Med. 2010;170(18):1622–31.

    CAS  PubMed  Google Scholar 

  68. Bronstrup A, Hages M, Pietrzik K. Lowering of homocysteine concentrations in elderly men and women. Int J Vitam Nutr Res. 1999;69(3):187–93.

    CAS  PubMed  Google Scholar 

  69. Brouwer IA, van Dusseldorp M, Thomas CM, Duran M, Hautvast J, Eskes T, et al. Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial. Am J Clin Nutr. 1999;69:99–104.

    CAS  PubMed  Google Scholar 

  70. Selhub J, Jacques PF, Wilson PF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993;270:2693–8.

    CAS  PubMed  Google Scholar 

  71. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;354(15):1567–77.

    CAS  PubMed  Google Scholar 

  72. Bønaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006;354(15):1578–88.

    PubMed  Google Scholar 

  73. Zhou YH, Tang JY, Wu MJ, Lu J, Wei X, Qin YY, et al. Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis. PLoS One. 2011;6(9):e25142.

    CAS  PubMed Central  PubMed  Google Scholar 

  74. Miller III ER, Juraschek S, Pastor-Barriuso R, Bazzano LA, Appel LJ, Guallar E. Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels. Am J Cardiol. 2010;106(4):517–27.

    PubMed  Google Scholar 

  75. Huo Y, Qin X, Wang J, Sun N, Zeng Q, Xu X, et al. Efficacy of folic acid supplementation in stroke prevention: new insight from a meta-analysis. Int J Clin Pract. 2012;66(6):544–51.

    CAS  PubMed  Google Scholar 

  76. Bailey RL, Dodd KW, Gahche JJ, Dwyer JT, McDowell MA, Yetley EA, et al. Total folate and folic acid intake from foods and dietary supplements in the United States: 2003–2006. Am J Clin Nutr. 2010;91(1):231–7.

    CAS  PubMed Central  PubMed  Google Scholar 

  77. Kim YI. Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies. Environ Mol Mutagen. 2004;44(1):10–25.

    CAS  PubMed  Google Scholar 

  78. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr. 2002;132(8 Suppl):2350S–5.

    CAS  PubMed  Google Scholar 

  79. Mason JB, Dickstein A, Jacques PF, Haggarty P, Selhub J, Dallal G, et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev. 2007;16(7):1325–9.

    CAS  PubMed  Google Scholar 

  80. Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF, Johnson KA, Johnson C, Buys SS, et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr. 2006;83(4):895–904.

    CAS  PubMed  Google Scholar 

  81. Plassman BL, Williams Jr JW, Burke JR, Holsinger T, Benjamin S. Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med. 2010;153(3):182–93.

    PubMed  Google Scholar 

  82. Institute of Medicine. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington, DC: National Academies Press; 1998.

    Google Scholar 

  83. Schneider JA, Tangney CC, Morris MC. Folic acid and cognition in older persons. Expert Opin Drug Saf. 2006;5(4):511–22.

    CAS  PubMed  Google Scholar 

  84. Seshadri S, Beiser A, Selhub J, Jaques PF, Rosenberg IH, D’Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med. 2002;346:476–83.

    CAS  PubMed  Google Scholar 

  85. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr. 2005;82(3):636–43.

    CAS  PubMed  Google Scholar 

  86. Eussen SJ, de Groot LC, Joosten LW, Bloo RJ, Clarke R, Ueland PM, et al. Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial. Am J Clin Nutr. 2006;84(2):361–70.

    CAS  PubMed  Google Scholar 

  87. Durga J, van Boxtel MPJ, Schouten EG, Kok FJ, Jolles J, Katan MB, et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet. 2007;369(9557):208–16.

    CAS  PubMed  Google Scholar 

  88. Malouf R, Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev. 2008;4, CD004514.

    PubMed  Google Scholar 

  89. Ford AH, Almeida OP. Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials. J Alzheimers Dis. 2012;29(1):133–49.

    CAS  PubMed  Google Scholar 

  90. Jia X, McNeill G, Avenell A. Does taking vitamin, mineral and fatty acid supplements prevent cognitive decline? A systematic review of randomized controlled trials. J Hum Nutr Diet. 2008;21(4):317–36.

    CAS  PubMed  Google Scholar 

  91. Cranney A, Horsley T, O’Donnell S, Weiler H, Puil L, Ooi D, et al. Effectiveness and safety of vitamin D in relation to bone health (prepared by University of Ottawa Evidence-based Practice Center, under contract No. 290-02-0021). Evidence Report/Technology Assessment No 158. Rockville, MD: Agency for Healthcare Research and Quality; 2007

    Google Scholar 

  92. Cranney A, Horsley T, O’Donnell S, Weiler H, Puil L, Ooi D, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep). 2007;(158):1–235.

    Google Scholar 

  93. Muir SW, Montero-Odasso M. Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. J Am Geriatr Soc. 2011;59(12):2291–300.

    PubMed  Google Scholar 

  94. Murad MH, Elamin KB, Abu Elnour NO, Elamin MB, Alkatib AA, Fatourechi MM, et al. Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96(10):2997–3006.

    CAS  PubMed  Google Scholar 

  95. Kalyani RR, Stein B, Valiyil R, Manno R, Maynard JW, Crews DC. Vitamin D treatment for the prevention of falls in older adults: systematic review and meta-analysis. J Am Geriatr Soc. 2010;58(7):1299–310.

    PubMed Central  PubMed  Google Scholar 

  96. Cameron ID, Gillespie LD, Robertson MC, Murray GR, Hill KD, Cumming RG, et al. Interventions for preventing falls in older people in care facilities and hospitals. Cochrane Database Syst Rev. 2012;12, CD005465.

    PubMed  Google Scholar 

  97. Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, Gates S, Clemson LM, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2012;9, CD007146.

    PubMed  Google Scholar 

  98. Stockton KA, Mengersen K, Paratz JD, Kandiah D, Bennell KL. Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos Int. 2011;22(3):859–71.

    CAS  PubMed  Google Scholar 

  99. Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med. 2012;367(1):40–9.

    CAS  PubMed  Google Scholar 

  100. Ma Y, Zhang P, Wang F, Yang J, Liu Z, Qin H. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol. 2011;29(28):3775–82.

    CAS  PubMed  Google Scholar 

  101. Balion C, Griffith LE, Strifler L, Henderson M, Patterson C, Heckman G, et al. Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology. 2012;79(13):1397–405.

    CAS  PubMed Central  PubMed  Google Scholar 

  102. Etgen T, Sander D, Bickel H, Sander K, Forstl H. Vitamin D deficiency, cognitive impairment and dementia: a systematic review and meta-analysis. Dement Geriatr Cogn Disord. 2012;33(5):297–305.

    CAS  PubMed  Google Scholar 

  103. Elamin MB, Abu Elnour NO, Elamin KB, Fatourechi MM, Alkatib AA, Almandoz JP, et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96(7):1931–42.

    CAS  PubMed  Google Scholar 

  104. Wang H, Xia N, Yang Y, Peng DQ. Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials. Lipids Health Dis. 2012;11:42.

    CAS  PubMed Central  PubMed  Google Scholar 

  105. George PS, Pearson ER, Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med. 2012;29(8):e142–50.

    CAS  PubMed  Google Scholar 

  106. Wu SH, Ho SC, Zhong L. Effects of vitamin D supplementation on blood pressure. South Med J. 2010;103(8):729–37.

    PubMed  Google Scholar 

  107. Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens. 2009;27(10):1948–54.

    CAS  PubMed  Google Scholar 

  108. Dereska NH, McLemore EC, Tessier DJ, Bash DS, Brophy CM. Short-term, moderate dosage vitamin E supplementation may have no effect on platelet aggregation, coagulation profile, and bleeding time in healthy individuals. J Surg Res. 2006;132(1):121–9.

    CAS  PubMed  Google Scholar 

  109. Meydani SN, Meydani M, Blumberg JB, Leka LS, Pedrosa M, Diamond R, et al. Assessment of the safety of supplementation with different amounts of vitamin E in older adults. Am J Clin Nutr. 1998;68:311–8.

    CAS  PubMed  Google Scholar 

  110. Morinobu T, Ban R, Yoshikawa S, Murata T, Tamai H. The safety of high-dose vitamin E supplementation in healthy Japanese male adults. J Nutr Sci Vitaminol (Tokyo). 2002;48(1):6–9.

    CAS  Google Scholar 

  111. Blumberg JB. An update: vitamin E supplementation and heart disease. Nutr Clin Care. 2002;5(2):50–5.

    PubMed  Google Scholar 

  112. Traber MG. Heart disease and single-vitamin supplementation. Am J Clin Nutr. 2007;85(1):293S–9.

    CAS  PubMed  Google Scholar 

  113. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342(3):154–60.

    CAS  PubMed  Google Scholar 

  114. Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Hartman AM, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst. 1998;18:440–6.

    Google Scholar 

  115. Virtamo J, Pietinen P, Huttunen JK, Korhonen P, Malila N, Virtanen MJ, et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA. 2003;290(4):476–85.

    CAS  PubMed  Google Scholar 

  116. Wright ME, Lawson KA, Weinstein SJ, Pietinen P, Taylor PR, Virtamo J, et al. Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr. 2006;84(5):1200–7.

    CAS  PubMed  Google Scholar 

  117. Cho E, Hunter DJ, Spiegelman D, Albanes D, Beeson WL, van den Brandt PA, et al. Intakes of vitamins A, C and E and folate and multivitamins and lung cancer: a pooled analysis of 8 prospective studies. Int J Cancer. 2006;118(4):970–8.

    CAS  PubMed  Google Scholar 

  118. Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, et al. SELECT: the next prostate cancer prevention trial. Selenium and Vitamin E Cancer Prevention Trial. J Urol. 2001;166:1311–5.

    CAS  PubMed  Google Scholar 

  119. Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, Bandera EV, et al. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012;62(1):30–67.

    PubMed  Google Scholar 

  120. U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary guidelines for Americans, 2010 7th Edition. Washington, DC: 2010 December 2010. US Goverment Printing Office.

    Google Scholar 

  121. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114:82–96.

    PubMed  Google Scholar 

  122. Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006;47(2):296–308.

    CAS  PubMed  Google Scholar 

  123. Institute of Medicine. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington, DC: National Academies Press; 2000.

    Google Scholar 

  124. U.S. Department of Agriculture, Agricultural Research Service. What we eat in America, 2009–2010 [updated July 16, 2012]. Available from: http://www.ars.usda.gov/Services/docs.htm?docid=18349.

  125. U.S. Food and Drug Administration. Qualified health claims subject to enforcement discretion: selenium & cancer, Docket No. 02P-0457. Washington, DC: Food and Drug Administration; 2003 [cited 2013 June 20]. Available from: http://www.fda.gov/Food/IngredientsPackagingLabeling/LabelingNutrition/ucm073992.htm#selenium.

  126. Piekutowski K, Makarewicz R, Zachara BA. The antioxidative role of selenium in pathogenesis of cancer of the female reproductive system. Neoplasma. 2007;54:374–8.

    CAS  PubMed  Google Scholar 

  127. Chen Y, Hall M, Graziano JH, Slavkovich V, van Geen A, Parvez F, et al. A prospective study of blood selenium levels and the risk of arsenic-related premalignant skin lesions. Cancer Epidemiol Biomarkers Prev. 2007;16(2):207–13.

    CAS  PubMed Central  PubMed  Google Scholar 

  128. Brinkman M, Reulen RC, Kellen E, Buntinx F, Zeeers M. Are men with low selenium levels at increased risk of prostate cancer? Eur J Cancer. 2006;42:2463–71.

    CAS  PubMed  Google Scholar 

  129. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301(1):39–51.

    CAS  PubMed Central  PubMed  Google Scholar 

  130. Nicastro HL, Dunn BK. Selenium and prostate cancer prevention: insights from the selenium and vitamin E cancer prevention trial (SELECT). Nutrients. 2013;5(4):1122–48.

    CAS  PubMed Central  PubMed  Google Scholar 

  131. Bleys J, Navas-Acien A, Guallar E. Serum selenium and diabetes in U.S. adults. Diabetes Care. 2007;30(4):829–34.

    CAS  PubMed  Google Scholar 

  132. Stranges S, Marshall JR, Trevisan M, Natarajan R, Donahue RP, Combs GF, et al. Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial. Am J Epidemiol. 2006;163:694–9.

    PubMed  Google Scholar 

  133. Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med. 2007;147:217–23.

    PubMed  Google Scholar 

  134. Hodge W, Barnes D, Schachter H, Pan Y, Lowcock E, Zhang L, et al. Effects of omega-3 fatty acids on eye health. Rockville, MD: Agency for Healthcare Research and Quality; 2005. Contract No.: AHRQ Publication No. 04-E012-2.

    Google Scholar 

  135. Lewin GA, Schachter HM, Yuen D, Merchant P, Mamaladze V, Tsertsvadze A. Effects of omega-3 fatty acids on child and maternal health. Rockville, MD: Agency for Healthcare Research and Quality; 2005. Contract No.: AHRQ Publication No. 05-E025-2.

    Google Scholar 

  136. Schachter H, Kourad K, Merali Z, Lumb A, Tran K, Miguelez M, et al. Effects of omega-3 fatty acids on mental health. Rockville, MD: Agency for Healthcare Research and Quality; 2005. Contract No.: AHRQ Publication No. 05-E022-2.

    Google Scholar 

  137. Schachter H, Reisman J, Tran K, Dales B, Kourad K, Barnes D, et al. Health effects of omega-3 fatty acids on asthma. Rockville, MD: 2004 Contract No.: AHRQ Publication No. 04-E013-2.

    Google Scholar 

  138. Maclean CH, Issa AM, Newberry SJ, Mojica WA, Morton SC, Garland RH, et al. Effects of omega-3 fatty acids on cognitive function with aging, dementia, and neurological diseases. Evid Rep Technol Assess (Summ). 2005;(114):1–3.

    Google Scholar 

  139. MacLean CH, Mojica WA, Morton SC, Pencharz J, Hasenfeld Garland R, Tu W, et al. Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis. Rockville, MD: Agency for Healthcare Research and Quality; 2004. Contract No.: AHRQ Publication No. 04-E012-2.

    Google Scholar 

  140. MacLean CH, Newberry SJ, Mojica WA, Issa A, Khanna P, Lim YW, et al. Effects of omega-3 fatty acids on cancer. Rockville, MD: Agency for Healthcare Research and Quality; 2005. Contract No.: AHRQ Publication No. 05-E010-2.

    Google Scholar 

  141. MacLean CH, Newberry SJ, Mojica WA, Khanna P, Issa AM, Suttorp MJ, et al. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA. 2006;295(4):403–15.

    CAS  PubMed  Google Scholar 

  142. Balk E, Chung M, Lichtenstein A, Chew P, Kupelnick B, Lawrence A, et al. Effects of omega-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease. Rockville, MD: Agency for Healthcare Research and Quality; 2004. Contract No.: AHRQ Publication No. 04-E010-2.

    Google Scholar 

  143. Jordan H, Matthan N, Chung M, Balk E, Chew P, Kupelnick B, et al. Effects of omega-3 fatty acids on arrhythmogenic mechanisms in animal and isolated organ/cell culture studies. Rockville, MD: Agency for Healthcare Research and Quality; 2004. Contract No.: AHRQ Publication No 04-E011-2.

    Google Scholar 

  144. Wang C, Chung M, Lichtenstein A, Balk E, Kupelnick B, DeVine D, et al. Effects of omega-3 fatty acids on cardiovascular disease. Rockville, MD: Agency for Healthcare Research and Quality; 2004. Contract No.: AHRQ Publication No. 04-E009-2.

    Google Scholar 

  145. Calder PC. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids. 2006;75(3):197–202.

    CAS  PubMed  Google Scholar 

  146. de Lorgeril M. Essential polyunsaturated fatty acids, inflammation, atherosclerosis and cardiovascular diseases. Subcell Biochem. 2007;42:283–97.

    PubMed  Google Scholar 

  147. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet. 1999;354:447–55.

    Google Scholar 

  148. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007;369:1090–8.

    CAS  PubMed  Google Scholar 

  149. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ, et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ. 2006;332:752–60.

    CAS  PubMed Central  PubMed  Google Scholar 

  150. Wang Q, Liang X, Wang L, Lu X, Huang J, Cao J, et al. Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials. Atherosclerosis. 2012;221(2):536–43.

    CAS  PubMed  Google Scholar 

  151. Khawaja O, Gaziano JM, Djousse L. A meta-analysis of omega-3 fatty acids and incidence of atrial fibrillation. J Am Coll Nutr. 2012;31(1):4–13.

    CAS  PubMed  Google Scholar 

  152. Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA. 2012;308(10):1024–33.

    CAS  PubMed  Google Scholar 

  153. Kwak SM, Myung SK, Lee YJ, Seo HG. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med. 2012;172(9):686–94.

    CAS  PubMed  Google Scholar 

  154. McKenney JM, Sica D. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia. Pharmacotherapy. 2007;5:715–28.

    Google Scholar 

  155. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2003;23(2):e20–30.

    CAS  PubMed  Google Scholar 

  156. Smith Jr SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113(19):2363–72.

    PubMed  Google Scholar 

  157. National Heart, Lung, and Blood Institute. Your guide to lowering Your cholesterol with TLC: National Heart, Lung, and Blood Institute; 2006 [cited 2013 June 20]. Available from: http://www.nhlbi.nih.gov/health/public/heart/chol/chol_tlc.pdf.

  158. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60(24):e44–164.

    PubMed  Google Scholar 

  159. Larsson SC, Kumlin M, Ingelman-Sundberg J, Wolk A. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr. 2004;79(6):935–45.

    CAS  PubMed  Google Scholar 

  160. Pardini RS. Nutritional intervention with omega-3 fatty acids enhances tumor response to anti-neoplastic agents. Chem Biol Interact. 2006;162(2):89–105.

    CAS  PubMed  Google Scholar 

  161. Shen XJ, Zhou JD, Dong JY, Ding WQ, Wu JC. Dietary intake of n-3 fatty acids and colorectal cancer risk: a meta-analysis of data from 489,000 individuals. Br J Nutr. 2012;108(9):1550–6.

    CAS  PubMed  Google Scholar 

  162. Szymanski KM, Wheeler DC, Mucci LA. Fish consumption and prostate cancer risk: a review and meta-analysis. Am J Clin Nutr. 2010;92(5):1223–33.

    CAS  PubMed  Google Scholar 

  163. Carayol M, Grosclaude P, Delpierre C. Prospective studies of dietary alpha-linolenic acid intake and prostate cancer risk: a meta-analysis. Cancer Causes Control. 2010;21(3):347–55.

    PubMed  Google Scholar 

  164. Wu S, Liang J, Zhang L, Zhu X, Liu X, Miao D. Fish consumption and the risk of gastric cancer: systematic review and meta-analysis. BMC Cancer. 2011;11:26.

    PubMed Central  PubMed  Google Scholar 

  165. Mazereeuw G, Lanctot KL, Chau SA, Swardfager W, Herrmann N. Effects of omega-3 fatty acids on cognitive performance: a meta-analysis. Neurobiol Aging. 2012;33(7):1482 e17–29.

    Google Scholar 

  166. Sydenham E, Dangour AD, Lim WS. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev. 2012;6, CD005379.

    PubMed  Google Scholar 

  167. Klein MA, Nahin RL, Messina MJ, Rader JI, Thompson LU, Badger TM, et al. Guidance from an NIH workshop on designing, implementing, and reporting clinical studies of soy interventions. J Nutr. 2010;140(6):1192S–204.

    CAS  PubMed Central  PubMed  Google Scholar 

  168. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation. 2006;113(7):1034–44.

    CAS  PubMed  Google Scholar 

  169. Anderson JW, Bush HM. Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies. J Am Coll Nutr. 2011;30(2):79–91.

    CAS  PubMed  Google Scholar 

  170. Harland JI, Haffner TA. Systematic review, meta-analysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol. Atherosclerosis. 2008;200(1):13–27.

    CAS  PubMed  Google Scholar 

  171. Taku K, Umegaki K, Ishimi Y, Watanabe S. Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: meta-analysis of randomized controlled trials. Ther Clin Risk Manag. 2008;4(5):1097–103.

    CAS  PubMed Central  PubMed  Google Scholar 

  172. Hodis HN, Mack WJ, Kono N, Azen SP, Shoupe D, Hwang-Levine J, Petitti D, Whitfield-Maxwell L, Yan M, Franke AA, Selzer RH for the WISH Research Group. Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial. Stroke. 2011;42(11):3168–75.

    Google Scholar 

  173. Henderson VW, St John JA, Hodis HN, Kono N, McCleary CA, Franke AA, Mack WJ for the WISH Research Group. Long term soy isoflavone supplementation and cognition in women: a randomized controlled trial. Neurology. 2012;78:1841–8.

    Google Scholar 

  174. Hendrix SL, Wassertheil-Smoller S, Johnson KC, Howard BV, Kooperberg C, Rossouw JE, et al. Effects of conjugated equine estrogen on stroke in the Women’s Health Initiative. Circulation. 2006;113(20):2425–34.

    CAS  PubMed  Google Scholar 

  175. Stefanick ML, Anderson GL, Margolis KL, Hendrix SL, Rodabough RJ, Paskett ED, et al. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA. 2006;295(14):1647–57.

    CAS  PubMed  Google Scholar 

  176. Liu J, Ho SC, Su YX, Chen WQ, Zhang CX, Chen YM. Effect of long-term intervention of soy isoflavones on bone mineral density in women: a meta-analysis of randomized controlled trials. Bone. 2009;44(5):948–53.

    CAS  PubMed  Google Scholar 

  177. Taku K, Melby MK, Nishi N, Omori T, Kurzer MS. Soy isoflavones for osteoporosis: an evidence-based approach. Maturitas. 2011;70(4):333–8.

    CAS  PubMed  Google Scholar 

  178. Wei P, Liu M, Chen Y, Chen DC. Systematic review of soy isoflavone supplements on osteoporosis in women. Asian Pac J Trop Med. 2012;5(3):243–8.

    CAS  PubMed  Google Scholar 

  179. Ricci E, Cipriani S, Chiaffarino F, Malvezzi M, Parazzini F. Soy isoflavones and bone mineral density in perimenopausal and postmenopausal Western women: a systematic review and meta-analysis of randomized controlled trials. J Womens Health (Larchmt). 2010;19(9):1609–17.

    Google Scholar 

  180. North American Menopause Society. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause. 2010;17(1):25–54. quiz 5–6.

    Google Scholar 

  181. North American Menopause Society. The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause. 2012;19(3):257–71.

    Google Scholar 

  182. Hooper L, Ryder JJ, Kurzer MS, Lampe JW, Messina MJ, Phipps WR, et al. Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis. Hum Reprod Update. 2009;15(4):423–40.

    CAS  PubMed Central  PubMed  Google Scholar 

  183. Jacobs A, Wegewitz U, Sommerfeld C, Grossklaus R, Lampen A. Efficacy of isoflavones in relieving vasomotor menopausal symptoms—a systematic review. Mol Nutr Food Res. 2009;53(9):1084–97.

    CAS  PubMed  Google Scholar 

  184. Bolanos R, Del Castillo A, Francia J. Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis. Menopause. 2010;17(3):660–6.

    PubMed  Google Scholar 

  185. Taku K, Melby MK, Kronenberg F, Kurzer MS, Messina M. Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials. Menopause. 2012;19(7):776–90.

    PubMed  Google Scholar 

  186. Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW, et al., editors. Complete German Commission E monographs: therapeutic guide to herbal medicines. Austin, TX: American Botanical Council; 1998.

    Google Scholar 

  187. Burdette JE, Liu J, Chen SN, Fabricant DS, Piersen CE, Barker EL, et al. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem. 2003;51(19):5661–70.

    CAS  PubMed  Google Scholar 

  188. Maki PM, Rubin LH, Fornelli D, Drogos L, Banuvar S, Shulman LP, et al. Effects of botanicals and combined hormone therapy on cognition in postmenopausal women. Menopause. 2009;16(6):1167–77.

    PubMed Central  PubMed  Google Scholar 

  189. Geller SE, Shulman LP, van Breemen RB, Banuvar S, Zhou Y, Epstein G, et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause. 2009;16(6):1156–66.

    PubMed Central  PubMed  Google Scholar 

  190. Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med. 2006;145(12):869–79.

    PubMed  Google Scholar 

  191. Shams T, Setia MS, Hemmings R, McCusker J, Sewitch M, Ciampi A. Efficacy of black cohosh-containing preparations on menopausal symptoms: a meta-analysis. Altern Ther Health Med. 2010;16(1):36–44.

    PubMed  Google Scholar 

  192. van der Sluijs CP, Bensoussan A, Chang S, Baber R. A randomized placebo-controlled trial on the effectiveness of an herbal formula to alleviate menopausal vasomotor symptoms. Menopause. 2009;16(2):336–44.

    PubMed  Google Scholar 

  193. Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database Syst Rev. 2012;9, CD007244.

    PubMed  Google Scholar 

  194. Amsterdam JD, Yao Y, Mao JJ, Soeller I, Rockwell K, Shults J. Randomized, double-blind, placebo-controlled trial of Cimicifuga racemosa (black cohosh) in women with anxiety disorder due to menopause. J Clin Psychopharmacol. 2009;29(5):478–83.

    PubMed Central  PubMed  Google Scholar 

  195. Schulz V, Hansel R, Tyler VE. Rational phytotherapy: a physician’s guide to herbal medicine. 4th ed. Berlin: Springer; 2001.

    Google Scholar 

  196. Therapeutic Research Faculty. Natural Medicines Comprehensive Database [Internet]. Stockton, CA: Therapeutic Research Center; 1995–2013 [cited 2013 June 20]. Available from: http://www.naturaldatabase.com. Subscription required.

  197. Koch E, Biber A. Pharmacological effects of sabal and urtica extracts as basis for a rational drug therapy in benign prostate hyperplasia. Urologe. 1994;34(2):90–5.

    Google Scholar 

  198. Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ. Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2012;12, CD001423.

    PubMed  Google Scholar 

  199. Bent S, Kane C, Shinohara K, Neuhaus J, Hudes ES, Goldberg H, et al. Saw palmetto for benign prostatic hyperplasia. N Engl J Med. 2006;354(6):557–66.

    CAS  PubMed  Google Scholar 

  200. Barry MJ, Meleth S, Lee JY, Kreder KJ, Avins AL, Nickel JC, et al. Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. JAMA. 2011;306(12):1344–51.

    CAS  PubMed Central  PubMed  Google Scholar 

  201. Agbabiaka TB, Pittler MH, Wider B, Ernst E. Serenoa repens (saw palmetto): a systematic review of adverse events. Drug Saf. 2009;32(8):637–47.

    PubMed  Google Scholar 

  202. Avins AL, Bent S, Staccone S, Badua E, Padula A, Goldberg H, et al. A detailed safety assessment of a saw palmetto extract. Complement Ther Med. 2008;16(3):147–54.

    PubMed Central  PubMed  Google Scholar 

  203. Oken BS, Storzbach DM, Kaye JA. The efficacy of Ginkgo biloba on cognitive function in Alzheimer’s disease. Arch Neurol. 1998;55:1409–15.

    CAS  PubMed  Google Scholar 

  204. Ernst E, Pittler MH. Ginkgo biloba for dementia: a systematic review of double-blind placebo controlled trials. Clin Drug Invest. 1999;17:301–8.

    Google Scholar 

  205. DeKosky ST, Williamson JD, Fitzpatrick AL, Kronmal RA, Ives DG, Saxton JA, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA. 2008;300(19):2253–62.

    CAS  PubMed Central  PubMed  Google Scholar 

  206. Nahin RL, Fitzpatrick AL, Williamson JD, Burke GL, DeKosky ST, Furberg C, et al. Use of herbal medicine and other dietary supplements in community-dwelling older people: baseline data from the ginkgo evaluation of memory study. J Am Geriatr Soc. 2006;54:1725–35.

    PubMed  Google Scholar 

  207. Vellas B, Andrieu S, Ousset PJ, Ouzid M, Mathiex-Fortunet H, GuidAge Study Group. The GuidAge study: methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint. Neurology. 2006;67(9 Suppl 3):S6–11.

    CAS  PubMed  Google Scholar 

  208. Vellas B, Coley N, Ousset PJ, Berrut G, Dartigues JF, Dubois B, et al. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer’s disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol. 2012;11(10):851–9.

    CAS  PubMed  Google Scholar 

  209. Birks J, Evans Grimley J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2009;1, CD003120.

    PubMed  Google Scholar 

  210. Laws KR, Sweetnam H, Kondel TK. Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis. Hum Psychopharmacol. 2012;27(6):527–33.

    CAS  PubMed  Google Scholar 

  211. Wang BS, Wang H, Song YY, Qi H, Rong ZX, Wang BS, et al. Effectiveness of standardized Ginkgo biloba extract on cognitive symptoms of dementia with a six-month treatment: a bivariate random effect meta-analysis. Pharmacopsychiatry. 2010;43(3):86–91.

    PubMed  Google Scholar 

  212. Weinmann S, Roll S, Schwarzbach C, Vauth C, Willich SN. Effects of Ginkgo biloba in dementia: systematic review and meta-analysis. BMC Geriatr. 2010;10:14.

    PubMed Central  PubMed  Google Scholar 

  213. He D, Zhou H, Guo D, Hao Z, Wu B. Pharmacologic treatment for memory disorder in multiple sclerosis. Cochrane Database Syst Rev. 2011;10, CD008876.

    PubMed  Google Scholar 

  214. Engelsen J, Nielsen JD, Winther K. Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients. A randomised, double blind, placebo-crossover trial. Thromb Haemost. 2002;87(6):1075–6.

    CAS  PubMed  Google Scholar 

  215. Wolf HR. Does Ginkgo biloba special extract EGb 761 provide additional effects on coagulation and bleeding when added to acetylsalicylic acid 500 mg daily? Drugs R D. 2006;7(3):163–72.

    CAS  PubMed  Google Scholar 

  216. Kellermann AJ, Kloft C. Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy. 2011;31(5):490–502.

    CAS  PubMed  Google Scholar 

  217. Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Welch V, et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2009;4, CD002946. doi:10.1002/14651858.CD002946.pub2.

    Google Scholar 

  218. Sawitzke AD, Shi H, Finco MF, Dunlop DD, Harris CL, Singer NG, et al. Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT. Ann Rheum Dis. 2010;69(8):1459–64.

    CAS  PubMed Central  PubMed  Google Scholar 

  219. Wilkens P, Scheel IB, Grundnes O, Hellum C, Storheim K. Effect of glucosamine on pain-related disability in patients with chronic low back pain and degenerative lumbar osteoarthritis: a randomized controlled trial. JAMA. 2010;304(1):45–52.

    CAS  PubMed  Google Scholar 

  220. Stuber K, Sajko S, Kristmanson K. Efficacy of glucosamine, chondroitin, and methylsulfonylmethane for spinal degenerative joint disease and degenerative disc disease: a systematic review. J Can Chiropr Assoc. 2011;55(1):47–55.

    PubMed Central  PubMed  Google Scholar 

  221. Wandel S, Juni P, Tendal B, Nuesch E, Villiger PM, Welton NJ, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ. 2010;341:c4675.

    PubMed Central  PubMed  Google Scholar 

  222. Lee YH, Woo JH, Choi SJ, Ji JD, Song GG. Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis. Rheumatol Int. 2010;30(3):357–63.

    CAS  PubMed  Google Scholar 

  223. Black C, Clar C, Henderson R, MacEachern C, McNamee P, Quayyum Z, et al. The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. Health Technol Assess. 2009;13(52):1–148.

    CAS  PubMed  Google Scholar 

  224. Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010;18(4):476–99.

    CAS  PubMed  Google Scholar 

  225. Richmond J, Hunter D, Irrgang J, Jones MH, Levy B, Marx R, et al. Treatment of osteoarthritis of the knee (nonarthroplasty). J Am Acad Orthop Surg. 2009;17(9):591–600.

    PubMed Central  PubMed  Google Scholar 

  226. Costello RB, Leser M, Coates PM. Dietary supplements: current knowledge and future frontiers. In: Bales CW, Ritchie CS, editors. Handbook of clinical nutrition and aging. 2nd ed. New York, NY: Humana Press; 2009. p. 553–633.

    Google Scholar 

  227. Rosenfeldt F, Hilton D, Pepe S, Krum H. Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure. Biofactors. 2003;18(1–4):91–100.

    CAS  PubMed  Google Scholar 

  228. Sander S, Coleman CI, Patel AA, Kluger J, White CM. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J Card Fail. 2006;12(6):464–72.

    CAS  PubMed  Google Scholar 

  229. Fotino AD, Thompson-Paul AM, Bazzano LA. Effect of coenzyme Q10 supplementation on heart failure: a meta-analysis. Am J Clin Nutr. 2013;97(2):268–75.

    CAS  PubMed Central  PubMed  Google Scholar 

  230. Davidson M, McKenney J, Stein E, Schrott H, Bakker-Arkena R, Fayyad R, et al. Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Am J Cardiol. 1997;79(11):1475–81.

    CAS  PubMed  Google Scholar 

  231. Caso G, Kelly P, McNurlan MA, Lawson WE. Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins. Am J Cardiol. 2007;99:1409–12.

    CAS  PubMed  Google Scholar 

  232. Marcoff L, Thompson PD. The role of coenzyme Q10 in statin-associated myopathy: a systematic review. J Am Coll Cardiol. 2007;49:2231–7.

    CAS  PubMed  Google Scholar 

  233. Bookstaver DA, Burkhalter NA, Hatzigeorgiou C. Effect of coenzyme Q10 supplementation on statin-induced myalgias. Am J Cardiol. 2012;110(4):526–9.

    CAS  PubMed  Google Scholar 

  234. Ho MJ, Bellusci A, Wright JM. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension. Cochrane Database Syst Rev. 2009;4, CD007435.

    PubMed  Google Scholar 

  235. Gao L, Mao Q, Cao J, Wang Y, Zhou X, Fan L. Effects of coenzyme Q10 on vascular endothelial function in humans: a meta-analysis of randomized controlled trials. Atherosclerosis. 2012;221(2):311–6.

    CAS  PubMed  Google Scholar 

  236. Young JM, Florkowski CM, Molyneux SL, McEwan RG, Frampton CM, Nicholls MG, et al. A randomized, double-blind, placebo-controlled crossover study of coenzyme Q10 therapy in hypertensive patients with the metabolic syndrome. Am J Hypertens. 2012;25(2):261–70.

    CAS  PubMed  Google Scholar 

  237. Dai YL, Luk TH, Yiu KH, Wang M, Yip PM, Lee SW, et al. Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: a randomized controlled trial. Atherosclerosis. 2011;216(2):395–401.

    CAS  PubMed  Google Scholar 

  238. Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol. 2002;59(10):1541–50.

    PubMed  Google Scholar 

  239. Shults CW, Flint Beal M, Song D, Fontaine D. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson’s disease. Exp Neurol. 2004;188(2):491–4.

    CAS  PubMed  Google Scholar 

  240. Storch A, Jost WH, Vieregge P, Spiegel J, Greulich W, Durner J, et al. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease. Arch Neurol. 2007;64(7):938–44.

    PubMed  Google Scholar 

  241. Liu J, Wang L, Zhan SY, Xia Y. Coenzyme Q10 for Parkinson’s disease. Cochrane Database Syst Rev. 2011;12, CD008150.

    PubMed  Google Scholar 

  242. Cohen MH, Hrbek A, Davis RB, Schachter SC, Eisenberg DM. Emerging credentialing practices, malpractice liability policies, and guidelines governing complementary and alternative medical practices and dietary supplement recommendations: a descriptive study of 19 integrative health care centers in the United States. Arch Intern Med. 2005;165(3):289–95.

    PubMed  Google Scholar 

  243. Bazzie KL, Witmer DR, Pinto B, Bush C, Clark J, Deffenbaugh Jr J. National survey of dietary supplement policies in acute care facilities. Am J Health Syst Pharm. 2006;63(1):65–70.

    PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank their colleagues in the Office of Dietary Supplements, especially Leila Saldanha, Ph.D., R.D., for their helpful comments.

Author information

Authors and Affiliations

  1. Office of Dietary Supplements, National Institutes of Health, 6100 Executive Blvd Room 3B01, MSC7517, Bethesda, MD, 20892, USA

    Johanna T. Dwyer D.Sc., R.D., Rebecca Costello Ph.D., Joyce Merkel M.S., R.D. & Paul M. Coates Ph.D.

Authors
  1. Johanna T. Dwyer D.Sc., R.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rebecca Costello Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joyce Merkel M.S., R.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paul M. Coates Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Johanna T. Dwyer D.Sc., R.D. .

Editor information

Editors and Affiliations

  1. Geriatric Research, Education, and Clinical Center, Department of Medicine, Durham VA Medical Center, Duke University Medical Center, Durham, North Carolina, USA

    Connie Watkins Bales

  2. Departments of Medicine and Health Care Organization and Policy Translational Nutrition and Aging Program, University of Alabama at Birmingham, Birmingham, Alabama, USA

    Julie L. Locher

  3. Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts, USA

    Edward Saltzman

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Dwyer, J.T., Costello, R., Merkel, J., Coates, P.M. (2015). Dietary Supplements in Older Adults. In: Bales, C., Locher, J., Saltzman, E. (eds) Handbook of Clinical Nutrition and Aging. Nutrition and Health. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1929-1_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1929-1_23

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-1928-4

  • Online ISBN: 978-1-4939-1929-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation